Literature DB >> 15671097

Ovarian steroidogenesis and serum androgen levels in patients with premature ovarian failure.

Anne Bachelot1, Géri Meduri, Nathalie Massin, Micheline Misrahi, Frédérique Kuttenn, Philippe Touraine.   

Abstract

Women with premature ovarian failure (POF) have been reported to have lower serum androgen levels compared with normal women. We reviewed the androgen profiles of 143 POF patients and found androgen levels above normal for postmenopausal women in 16% of these subjects. To determine the source of androgens in those women, we studied the available ovarian biopsy samples of 15 POF patients with increased androgen levels using immunohistochemistry, with a panel of antibodies directed against the main steroidogenic enzymes. Five of the ovarian biopsies exhibited abnormal follicles characterized by hypertrophied theca interna expressing steroidogenic enzymes involved in androgen synthesis. In five other biopsies, the steroidogenic activity was scarce and confined to a small number of ovarian stromal cells, sometimes situated in the proximity of follicular remnants. Finally, in five patients, we found no histological evidence of present or past follicular development beyond the quiescent follicular stage, and no steroidogenic cells were detected by immunohistochemistry. Our findings suggest that ovarian theca-derived cells are a source of androgens in some women with POF, whereas in others, as in most postmenopausal patients, the adrenals or the ovarian hilus cells may synthesize a significant quantity of androgens under LH stimulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671097     DOI: 10.1210/jc.2004-1734

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Luteinizing hormone correlates with adrenal function in postmenopausal women.

Authors:  Aditi R Saxena; Ellen W Seely
Journal:  Menopause       Date:  2012-11       Impact factor: 2.953

2.  High expression of antizyme inhibitor 2, an activator of ornithine decarboxylase in steroidogenic cells of human gonads.

Authors:  Laura T Mäkitie; Kristiina Kanerva; Anna Sankila; Leif C Andersson
Journal:  Histochem Cell Biol       Date:  2009-09-16       Impact factor: 4.304

3.  A network pharmacology approach to explore active compounds and pharmacological mechanisms of epimedium for treatment of premature ovarian insufficiency.

Authors:  Huishan Zhao; Yinghua Shan; Zhi Ma; Mingwei Yu; Benjiao Gong
Journal:  Drug Des Devel Ther       Date:  2019-08-22       Impact factor: 4.162

4.  Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome.

Authors:  Luciana Tock; Gláucia Carneiro; Andrea Z Pereira; Sérgio Tufik; Maria Teresa Zanella
Journal:  Int J Endocrinol       Date:  2014-05-07       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.